Skip to main content
. 2020 Feb 12;11(2):e00128. doi: 10.14309/ctg.0000000000000128

Figure 1.

Figure 1.

(a) Overall treatment pathways for UC depicted by Sankey diagrams. (b) First-line biologic treatment pathways for patients with UC. 5-ASA, 5-aminosalicylic acid; IMM, immunomodulator; Mono, monotherapy; other Combo Bio, other combination with a biologic; other Combo NonBio, other combination with a nonbiologic; UC, ulcerative colitis.